Source:http://linkedlifedata.com/resource/pubmed/id/14668552
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2003-12-11
|
pubmed:abstractText |
Anti-hepatocyte antibody, hepatocyte paraffin 1, is a monoclonal antibody that is highly specific for normal and neoplastic hepatocytes and that can differentiate hepatocytic from nonhepatocytic tumors. This marker has been rarely studied in extra-hepatic tumors and to our knowledge has not been investigated in ovarian tumors with hepatoid differentiation. We studied hepatocyte paraffin 1 immunoreactivity in a series of ovarian hepatoid carcinomas, ovarian hepatoid yolk sac tumors (YSTs), and hepatocellular carcinomas metastatic to the ovary to assess the potential utility of hepatocyte paraffin 1 in differential diagnosis. Hepatocyte paraffin 1 positivity was seen in three of seven ovarian hepatoid carcinomas, five of eight hepatoid yolk sac tumors, and six of eight metastatic hepatocellular carcinomas. The extent of positivity ranged from <25% to >50% of the tumor cells. There was strong coarsely granular cytoplasmic staining in all three tumor types without a distinctive staining pattern in any group. The degree of hepatic differentiation correlated with hepatocyte paraffin 1 positivity in the three groups: 83% of the well differentiated tumors, 50% of the moderately differentiated tumors, and none of the poorly differentiated tumors were positive. All ovarian hepatoid carcinomas were either immunoreactive for alpha-fetoprotein or had an elevated serum alpha-fetoprotein level; more than half of these tumors were hepatocyte paraffin 1 negative. All but one hepatocyte paraffin 1 negative hepatoid yolk sac tumor and ovarian hepatocellular carcinoma were also negative for alpha-fetoprotein. In conclusion, hepatocyte paraffin 1 is positive in primary ovarian tumors with hepatoid differentiation, with the degree of hepatocyte paraffin 1 positivity correlating with the degree of hepatoid differentiation. Hepatocyte paraffin 1, however, is not useful in distinguishing metastatic hepatocellular carcinoma from primary ovarian hepatoid carcinoma or hepatoid yolk sac tumor.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0277-1691
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
23
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
58-64
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:14668552-Adolescent,
pubmed-meshheading:14668552-Adult,
pubmed-meshheading:14668552-Aged,
pubmed-meshheading:14668552-Aged, 80 and over,
pubmed-meshheading:14668552-Antibodies, Monoclonal,
pubmed-meshheading:14668552-Carcinoma, Hepatocellular,
pubmed-meshheading:14668552-Child,
pubmed-meshheading:14668552-Diagnosis, Differential,
pubmed-meshheading:14668552-Female,
pubmed-meshheading:14668552-Hepatocytes,
pubmed-meshheading:14668552-Humans,
pubmed-meshheading:14668552-Immunohistochemistry,
pubmed-meshheading:14668552-Liver Neoplasms,
pubmed-meshheading:14668552-Ovarian Neoplasms,
pubmed-meshheading:14668552-Sensitivity and Specificity,
pubmed-meshheading:14668552-Tumor Markers, Biological,
pubmed-meshheading:14668552-alpha-Fetoproteins
|
pubmed:year |
2004
|
pubmed:articleTitle |
Hepatocyte paraffin 1 antibody does not distinguish primary ovarian tumors with hepatoid differentiation from metastatic hepatocellular carcinoma.
|
pubmed:affiliation |
James Homer Wright Pathology Laboratories, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA. mpitman@partners.org
|
pubmed:publicationType |
Journal Article,
Comparative Study
|